Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
J-NC: Conceptualization, Data curation, Methodology, Software, Writing review & editing
Clinical research and practice will continue to drive the development and application of osteosarcoma radiotherapy sensitizers, and more future clinical trials and studies are likely to assess the safety and efficacy of these agents, and ultimately, their application in clinical practice
Unit conversion is essential
Diabetes Care 40 , 694697 (2017)
Drug combination studies showed that NBDHEX is significantly active on cisplatin-resistant human osteosarcoma cells 77
"Bodybuilding changing, but it's still hard work"
US$ 26.43
US$ 29.76
US$ 22.33
US$ 24.03
US$ 26.19
US$ 26.37
US$ 23.05
US$ 20.92
